Exclusive look at our Italian contribution to The Life Sciences Law Review

The fourth edition of The Life Sciences Review was recently published which included valued contributions made by our IP and Life Sciences group in Italy.

Our chapter provides an overview of legal issues of interest to pharmaceutical, biotechnology and medical device companies in the Italian market. It contains information on legal requirements relating to the key stages in the life cycle of a regulated product, from discovery, through the clinical development process, registration, manufacturing and promotion, plus other issues of special interest, such as pricing and reimbursement, special liability regimes, competition and commercial transactions in the context of the medical products business.

The resulting work product will assist industry lawyers, regulatory affairs staff and others who need to have an understanding of the issues in each major market.

Please click here for the PDF version of the exclusive Italy chapter. If you would like to view the eBook or PDF version of the entire Life Sciences Law Review, please click on the image.

News & Deals

More News & Deals
Deal Bird & Bird advises Brose Sitech on the acquisition of Proseat including its subsidiaries from Sekisui Kasei

Jul 07 2025

Read More
News Bird & Bird strengthens market-leading patent practice with Anna Wolters-Höhne in Hamburg

Jul 07 2025

Read More
News Bird & Bird acts for Willis Mitsui & Co Engine Support Limited in Acquisition of Bridgend Asset Management Limited

Jul 04 2025

Read More
News Bird & Bird partner Bill Smith relocates to the Middle East to head the Dispute Resolution practice

Jul 02 2025

Read More
News Bird & Bird boosts Commercial team in Sweden with new partner Mårten Lindberg

Jul 01 2025

Read More
News Bird & Bird advises Gprnt on seed funding round

Jun 27 2025

Read More

Related capabilities